Day: March 15, 2023

A.I.S. Resources Appoints Andrew Neale to the Board of Directors

Written by Customer Service on March 15, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, March 15, 2023 (GLOBE NEWSWIRE) — A.I.S. Resources Limited (TSX.V: AIS, OTCQB: AISSF) (the “Company” or “AIS”) is pleased to announce the appointment of Andrew Neale as a director of the Company. Andrew is a Canadian engineer who has been involved in all aspects of the mining industry since the late 80s. Starting his career in Canada with Falconbridge and Noranda, Andrew joined PT Freeport Indonesia in 1993, completing his career with Freeport as VP–Technical Services in 2005 with wide ranging responsibilities for the Grasberg open pit and underground mines, including engineering and construction. Andrew also led the Freeport team that exposed the Bre-X (Busang) gold fraud. Andrew has worked extensively in Canada, Central and South America, and South-East Asia in various roles, ranging from CEO and...

Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany

Written by Customer Service on March 15, 2023. Posted in Public Companies.

Labor Staber to actively market and sell ColoAlert to its physician and patient network. BERKELEY, Calif. and MAINZ, Germany, March 15, 2023 (GLOBE NEWSWIRE) — Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a partnership with Dr Staber & Kollegen GmbH (Labor Staber) as part of its growing network of laboratories offering ColoAlert, its flagship product that is a highly efficacious and easy-to-use at-home screening test for colorectal cancer (CRC). For more than 35 years, Labor Staber has been providing physicians and hospitals with medical laboratory services at nine locations across Germany. “At Mainz, we are on a mission to save lives through the early detection of CRC – the third most common cancer globally...

2022: proving Cabka’s sound fundamentals

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

Record sales of € 208.9 million (2021: € 170.0 million) Operational EBITDA € 22.5 million (2021: € 29.0 million) Net Income from operations € 1.5 million (2021: € 3.4 million) Proposed distribution of € 0.15 per share Confirm mid-term guidance1Amsterdam 15 March 2023. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, announces its preliminary non-audited 2022 full year results. Cabka CEO Tim Litjens, commented:“In 2022 we continued our growth strategy, recording 23% topline growth. Whilst navigating economic and environmental challenges we demonstrated our intrinsic value-add and pricing power. We secured several major contracts in Customized Solutions, and expanded...

Nexus Industrial REIT Announces Full Year and Fourth Quarter 2022 Results, Acquisition Update and March Distribution

Written by Customer Service on March 15, 2023. Posted in Dividend Reports And Estimates.

TORONTO, March 14, 2023 (GLOBE NEWSWIRE) — Nexus Industrial REIT (the “REIT”) (TSX: NXR.UN) announced today its results for the year and quarter ended December 31, 2022. HighlightsOn March 7, 2023, the REIT acquired a newly constructed 532,000 square foot distribution centre located in Casselman, Ontario for $116.8 million. Successfully completed a bought deal financing on December 8, 2022, generating net proceeds of $80.5 million. On November 1, 2022, the REIT acquired a 435,871 square foot portfolio of four industrial properties occupied by a single tenant for $38.9 million ($28.5 USD million). Three of the properties are located in Windsor, Ontario and one is located in Tilbury, Ontario. Completed $316.8 million of industrial property acquisitions in 2022; increasing NOI from industrial properties to approximately 88% of NOI...

Pain Management Therapeutics Market is Expected to Surpass USD 97.23 Billion by 2028 at a CAGR of 4.3% from 2022-2028; Rising Prevalence of Chronic Pain Conditions and Demand for Pain Management Drugs to Boost Market Growth

Written by Customer Service on March 15, 2023. Posted in Mergers And Acquisitions.

The pain management therapeutics market is experiencing a surge in popularity, prompting a need for comprehensive analysis and insights. SkyQuest’s forthcoming report is anticipated to provide a valuable resource for industry professionals, investors, and other stakeholders seeking to understand this dynamic market better. The report covers market size, growth rate, drivers and challenges, and key trends. This information can be used by businesses to make informed decisions about their product pipeline, product offerings, pricing strategies, and distribution channels. Westford, USA,, March 14, 2023 (GLOBE NEWSWIRE) — The pain management therapeutics market is rapidly growing globally, with North America expected to take the lead position. This is due to the increasing prevalence of various diseases that cause pain and aches,...

Cielo Announces Fiscal Q3 2023 Financial Results and Conference Call Details

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, March 14, 2023 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”), a waste‐to‐fuel company, today announced its financial results for the three and nine months ended January 31, 2023. Copies of the unaudited interim financial statements and related management’s discussion and analysis can be found on the Company’s issuer profile at www.sedar.com. All financial information in this news release is reported in Canadian dollars, unless otherwise indicated. Jasdeep K. Dhaliwal, CFO of the Company stated “Over the previous eight months, the management team has strived to make strategic decisions to minimize our corporate expenses and allocate our expenditures to the fabrication of the R&D Facility. As we begin commissioning of the R&D facility, we...

Jounce Therapeutics Confirms Receipt of Unsolicited Proposal from Concentra Biosciences

Written by Customer Service on March 15, 2023. Posted in Mergers And Acquisitions.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. CAMBRIDGE, Mass., March 14, 2023 (GLOBE NEWSWIRE) — The Board of Directors (the “Board”) of Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today confirmed that Concentra Biosciences, LLC (“Concentra”), of which Tang Capital Partners, LP is the controlling shareholder, has made an unsolicited and non-binding proposal (“the Proposal”) to acquire 100% of the equity of Jounce. According to the Schedule 13D filed today with the U.S. Securities and Exchange Commission (“SEC”) disclosing the Proposal,...

Imperial Reports 2022 Financial Results

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, March 14, 2023 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports financial results for its fiscal year ended December 31, 2022.Select Annual Financial Information Years Ended December 31 expressed in thousands, except share and per share amounts 2022 2021 2020 Operations: Total revenues $172,797 $133,591 $148,097 Net loss $(75,975 ) $(26,070 ) $(4,892 )Net loss per share $(0.51 ) $(0.19 ) $(0.04 )Diluted loss per share $(0.51 ) $(0.19 ) $(0.04 )Adjusted net loss (1) $(95,598 ) $(23,181 ) $(5,421 )Adjusted net loss per share (1) $(0.64 ) $(0.17 ) $(0.04 )Adjusted EBITDA(1) $(63,131 ) $11,553 $36,034 Cash earnings (1)(2) $(52,873 ) $11,034 $36,909 Cash earnings per share (1)(2) $(0.36 ) $0.08 $0.29 Working...

Atlanticus Reports Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

Achieved Over $1 Billion in Annual Revenue with Another Consecutive Quarter of Revenue Growth ATLANTA, March 14, 2023 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” “the Company”, “we,” “our” or “us”), a financial technology company which enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced its financial results for the fourth quarter and full year ended December 31, 2022. An accompanying earnings presentation is available in the “Investors” section of the Company’s website at www.atlanticus.com or by clicking here. Financial and Operating Highlights Fourth Quarter 2022 Highlights (all comparisons to the Fourth Quarter 2021)Total operating revenue increased 24.1% to $268.7 million. Purchase volume increased...

Day: March 15, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice